Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JN.5ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
JN.5ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JN.5EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JN.5EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JN.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JG.3.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-1649.2South Korea
JG.3.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JG.3.4ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
JG.3.4ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JG.3.4EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JG.3.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JG.3.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JG.3.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.43EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.43EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.43ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.2.43ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.2.43EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.2.43EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.43ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.43ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HR.1.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
HR.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HR.1.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
HR.1.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HR.1.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
HR.1.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
HR.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HR.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.7EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
HK.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.7ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
HK.7ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HK.7EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
HK.7EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
HK.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HS.1.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
HS.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HS.1.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
HS.1.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HS.1.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
HS.1.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
HS.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HS.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HH.5EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
HH.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HH.5ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
HH.5ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used